Cefetamet pivoxil: Comparable evaluation with other orally available antibiotics against selected species of respiratory pathogens

Chemotherapy

Volumn 42, Issue 1, 1996, Pages 1-10

  Speciale, Annamaria ^a   Caccamo, F ^a   Blandino, G ^a   Giacchi, G T ^a   Aleo, G ^a   Nicoletti, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cefetamet pivoxil; Pathogens, respiratory; Lactamase stable

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFACLOR; CEFETAMET; CEFETAMET PIVOXIL; CEFTIBUTEN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG STABILITY; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HYDROLYSIS; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ADMINISTRATION, ORAL; ANTIBIOTICS; BETA-LACTAM RESISTANCE; CEFTIZOXIME; CEPHALOSPORINS; COMPARATIVE STUDY; HUMAN; MICROBIAL SENSITIVITY TESTS; PRODRUGS; RESPIRATORY TRACT DISEASES; SUPPORT, NON-U.S. GOV'T;

EID: 0029655235     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239417     Document Type: Article

References (24)

1. Cullmann W, Edwards DJ, Kissling M, Kneer J, Stoeckel K, Urwyler H: Cefetamet-pivoxil: A review of its microbiology, toxicology, pharmacokinetics and clinical efficacy. Int J Antimicrob Agents 1992;1:175-192.
2. Thomas MC, Lang SDR: Antimicrobial spectrum of Ro 15-8074/ 001, a new oral cephalosporin. Antimicrob Agents Chemother 1986; 29:945-947.
3. Aldridge KJE, Schiro DD, Sanders CV: Comparative in vitro activity of the two new oral cephalosporin metabolites Ro 19-5247 and Ro 15-8074. Eur J Clin Microbiol 1987;6: 564-569.
4. Chau PY, Leung YK, Ng WWS, Arnold K: Comparative in vitro antibacterial activities of two new oral cephalosporins, cefteram (Ro 19-5247) and cefetamet (Ro 15-8074). Antimicrob Agents Chemother 1987;31:473-476.
5. Jorgensen JH, Doem GV, Maher LA, Howell AW, Redding JS: Antimicrobial resistance among respiratory isolates of II. influenzae, M. catarrhalis and S. pneumoniae in the United States. Antimicrob Agents Chemother 1990;34:2075-2080.
6. Neu HC, Chin NX, Labthavikul P: In vitro activity and ß-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074). Antimicrob Agents Chemother. 1986,30:423-428.
7. Lcnncttc EH, Balows A, Hausier WJ Jr, Shadomy HJ: Manual of Clinical Microbiology, ed 4. Washington, American Society for Microbiology, 1985.
8. Neu HC: Antibiotic inactivating enzymes and bacterial resistance: in Lorian V (ed): Antibiotics in Laboratory Medicine, ed 2. Baltimore. Williams & Wilkins 1986, pp 757-789.
9. Matthew M, Harris AM: Identification of betalactamases by analytical isoelectric focusing: Correlation with bacterial taxonomy. J Gen Microbiol 1976;94:55-67.
10. National Committee for Clinical Laboratory Standards: Approved Standard M7-A2 - Standard Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria which Grow Aerobically, ed 2. Villanova, National Committee for Clinical Laboratory Standards. 1990
11. Jorgensen JH, Redding JS, Maher LA, Howell AW: Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.J Clin Microbiol 1987;25:2105-2113.
12. Jones RN, Barry AL: Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8024) and cefteram (Ro 19-5247) disk tests. J Clin Microbiol 1987;25: 1796-1799.
13. Kitzis MD, Liassine N, Ferré SB, Gutmann L, Acar JF, Goldstein F: In vitro activities of 15 oral ß-lacta-mases against Klebsiella pneumoniae harboring new extended spectrum ß-lactamases. Antimicrob Agents Chemother 1990;34:1783-1798.
14. Pearson PD, Stcigbigel RT, Davis HT, Chapman SW: Method for reliable determination of minimal lethal concentrations. Antimicrob Agents Chemother 1980:18:699-708.
15. Sykes RB, Mattcw M: Detection, assay and immunology of bctalacta-mases: in Hamilton-Miller JMT, Smith JT (eds): Beta-Lactamases. London. Academic Press, 1979, pp 17-50.
16. Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ: Pneumococcal Surveillance Working Group: Antimicrobial resistance of Streptococcus pneumoniae in the United States 1979-1987. Infect Dis 1991;163: 1273-1278.
17. Machka K, Braveny I, Dabernat K, Dornbusch K, van Dyck E, Kayser FH, van Klingeren B. Mittermayer M, Perea E, Powell M: Distribution and resistance patterns of Haemophilus influenzae: A European comparative study. Eur J Clin Microbiol Infect Dis 1988;7:14-24.
18. Stobberingh EE, Wunderink M, Philips M, Houben A: Branhamella catarrhalis. ß-Lactamase production and sensitivity to oral antibiotics including new cephalosporins. J Antimicrob Chemother 1987;20:765-770.
19. Mittermayer H: In vitro activity of cefetamet (Ro 15-8074). Eur J Clin Microbiol 1986;5:530-534.
20. Wise R, Andrews JM, Piddock LJV: In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites. Antimicrob Agents Chemother 1986;29:1067-1072.
21. Baucmfeind A, Jungwirth R: Antibacterial activity of ccfpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil. Infection 1991;19:353-362.
22. Debbia EA, Schito GC, Pesce A: Antibacterial activity of ceftibuten, a new oral third-generation cephalosporin. J Chemother 1991,3:209-225.
23. Wiedeman B, Lubmer E, Ziihlsdorf MT: In vitro activity of Cefpodoxime and ten other cephalosporins against gram-positive cocci, Entero-bacteriaceae and Pseudomonas aeruginosa including ß-lactamase producers. Infection 1991;19:353-382.
24. Stoeckel K: Pharmacokinetics of intravenous cefetamet and oral eefeta-met-pivoxil in human subjects. A review. Drug Invest 1991:3/5:291-298.